Quantitative structure-activity relationship study on some nonpeptidal cholecystokinin antagonists.

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Computational Chemistry

Background:

• Cholecystokinin (CCK) is a gastrointestinal peptide hormone with three receptor subtypes: CCK-A, CCK-B, and gastrin receptor.
• These receptors are implicated in various physiological processes and are targets for therapeutic intervention.

Purpose of the Study:

• To perform a quantitative structure-activity relationship (QSAR) analysis on 1,4-benzodiazepine derivatives as CCK receptor antagonists.
• To elucidate the key molecular features governing the binding affinity and selectivity of these compounds across CCK receptor subtypes.

Main Methods:

• Quantitative structure-activity relationship (QSAR) modeling was employed.
• Analysis focused on the relationship between chemical structure, lipophilicity, hydrogen bonding capacity, and receptor binding.

Main Results:

• 1,4-benzodiazepine derivatives were identified as antagonists for CCK receptors.
• Compound binding affinity significantly correlated with lipophilicity and hydrogen bonding potential.
• CCK-A receptor binding sites exhibited greater rigidity compared to CCK-B and gastrin receptors, which share similar binding site characteristics.

Conclusions:

• Lipophilicity and hydrogen bonding are critical determinants for 1,4-benzodiazepine derivative binding to CCK receptors.
• Structural differences in receptor binding sites, particularly the rigidity of CCK-A, influence antagonist interactions.
• These findings provide a basis for designing more selective and potent CCK receptor antagonists.